Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
<p>Abstract</p> <p>Backgrounds</p> <p>Cisplatin-based chemotherapy, in combination with fluoropyrimidines or taxanes, have demonstrated efficacy against advanced gastric cancer (AGC). This retrospective study was performed with the data obtained from our cancer chemothe...
Main Authors: | Kim Hyeong, Lee Hui-Young, Lee Sang-Cheol, Kwon Jung, Hwang In, Oh Sung, Kang Jung, Park Keon, Park Se, Lim Do, Lim Ho, Kang Won |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/583 |
Similar Items
-
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
by: Bang Soo-Mee, et al.
Published: (2006-01-01) -
Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
by: Eun Kyo Joung, et al.
Published: (2021-01-01) -
Metastatic lymph node in gastric cancer; Is it a real distant metastasis?
by: Noh Jae, et al.
Published: (2010-01-01) -
Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)
by: Wonjun Ji, et al.
Published: (2023-11-01) -
Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum‐based doublet chemotherapy and immunotherapy (SPACE study)
by: Seung Hyeun Lee, et al.
Published: (2021-04-01)